Signal2026-05-26
ClinicalTrials.gov

[PHASE1] Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Part of

Geriatric Illness And Health Studies

Open primary sourceSee the whole picture